Today’s top gainers include the company Gilead Sciences, Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining 0.00% today. In the last week its performance is 1.08%, and -5.44% for the past quarter. Currently, Gilead Sciences, Inc., GILD has a target price of 77.6, so today’s gain of 0.00% is a significant step towards its target price. The GAP today is therefore 0.00%.
Gilead Sciences, Inc. (NASDAQ:GILD), has a market cap of 84.95 B, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 76.90%.
At the current price of 64.81, it has a dividend yield of 3.21%, and its target price is 77.6. This is with a profit margin of 43.40%, and total debt/equity of 1.29. Gilead Sciences, Inc. (NASDAQ:GILD) has a P/E of 6.85, as well as a forward P/E of 8.73.
With a current EPS of 9.46, and a forecasted EPS growth for next year at -9.44%,Gilead Sciences, Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 41.20%. For the next five years EPS growth is projected to be -5.60%.
Performance for the year is -21.95%. Since its IPO date on 1/22/1992, the total performance to date is -9.50%.
Volume today for Gilead Sciences, Inc. (NASDAQ:GILD), is 0, while its average volume is 7629.67. Whilst the total gain today was 0.00%, it did have a day high of -6.29%.
Volatility for this week has been at 1.76%, and 1.27% for the month. The 52-week low for Gilead Sciences, Inc., GILD has been 1.46%, while the 52-week-high has reached -27.06%.
Looking at its return of investments, which is 31.00%, and its return on assets is 22.80%. Gilead Sciences, Inc. (NASDAQ:GILD) has an operating margin of 57.60%. With a sales growth of -16.50% quarter over quarter. Bearing in mind that Gilead Sciences, Inc., GILD is in the sector Healthcare, its long-term debt/equity is 1.29, and has a current ratio of 2.6 and 2.4 for quick ratio.
So what is the value of Gilead Sciences, Inc.? Well its PEG is *TBA, and the P/S is 2.92, along with a P/B of 4.15. Meanwhile it has a p/cash of 6.02.